
CAS 1600418-29-8
:Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]-
Description:
Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]- is a complex organic compound characterized by its intricate structure, which includes multiple functional groups and a significant molecular weight. This substance features a glycinamide backbone, indicating potential biological activity, particularly in peptide synthesis or as a pharmaceutical intermediate. The presence of a pyrrolidine ring and various substituents suggests it may exhibit unique chemical reactivity and potential interactions with biological targets. Its fluorinated and dioxo components may enhance its pharmacological properties, such as increased potency or selectivity. The compound's CAS number, 1600418-29-8, allows for precise identification in chemical databases, facilitating research and development in medicinal chemistry. Overall, this compound's structural complexity and functional diversity position it as a candidate for further investigation in drug discovery and development.
Formula:C49H51FN8O11
Synonyms:- Trastuzumab Impurity 1
- MC-GGFG-DX8951
- Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(
- Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(2-((2-(((S)-1-((2-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quino
CAS:6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-(2-((2-(((S)-1-((2-(((1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinoPurity:98%Molecular weight:946.99g/molMC-GGFG-DX8951
CAS:MC-GGFG-DX8951 is an antibody-coupled drug (ADC) drug-linker conjugate (DLC) consisting of DX8951, a potent DNA topoisomerase I inhibitor, antitumor .Formula:C49H51FN8O11Purity:99.04%Color and Shape:SolidMolecular weight:946.98MC-GGFG-DX8951
CAS:MC-GGFG-DX8951 is a peptide that binds to the extracellular domain of human EGFR. It has been shown to activate and inhibit the activity of this receptor. MC-GGFG-DX8951 is used as a research tool for pharmacology, cell biology, and biochemistry.
Formula:C49H51FN8O11Purity:Min. 95%Molecular weight:947 g/molRef: 3D-APC41829
Discontinued product


